Pravastatin Sodium Tablet
Product Images NDC 84386-034

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pravastatin Sodium (NDC 84386-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Pravastatin Fig1)

This information shows the proportion of subjects without coronary heart disease death or nonfatal myocardial infarction over a period of years since randomization. There is a significant difference between the placebo and Pravastatin groups as indicated by the Logrank P-value of 0.0001. The data suggests that Pravastatin may be associated with a higher survival rate compared to the placebo.*

FDA Label Image

Package Label-principal Display Panel (80 mg (90 Tablets Bottle))

This text contains information about tablets containing 80 mg of pravastatin sodium, manufactured in the Czech Republic. It provides guidelines for storage temperature, protection from light and moisture, and a reminder to keep medications out of reach of children. The text also mentions details for dispensing in a light-resistant container with a child-resistant closure and includes a National Drug Code (NDC) for identification. Additionally, it suggests that GTIN, Serial Number, Expiry Date, and LOT will be printed in the human Coding Area during packing.*

FDA Label Image

Chemical Structure (Pravastatin Str)

Chemical compound with the molecular weight of 446.52 g/mol.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.